Hepatitis A may not be on your radar, but with the current LA County outbreak, you may want to reacquaint yourself with this ...

Vir is holding off on advancing the combination therapy to Phase III trials in hepatitis B until it secures a development ...

The global hepatitis c testing market revenue was around US$ 1.8 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Vir Biotechnology (NASDAQ:VIR) on Friday announced 24-week post-end-of-treatment data from a mid-stage trial for tobevibart ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

To confirm viral hepatitis as the cause, a healthcare provider will give you a blood test that detects immune proteins called antibodies produced in response to the virus. Hepatitis A antibody tests ...

Fewer than 1 in 3 children with hepatitis C (HCV ... Centers for Disease Control and Prevention recommended universal HCV antibody screening during every pregnancy. “There’s still hope ...

For hematologic cancers, the past decade was marked by the rise of alternative immunotherapies such as antibody-drug conjugates (ADCs), bispecific antibodies that engage T cells (BsAbs), and chimeric ...

EpiBiologics, a leader in tissue-selective extracellular protein degradation, today presented the first preclinical data on its EpiTAC bispecific antibody degrader of c-Met, a potential first-in ...

People who ate at a Jersey Mike’s Subs restaurant in Oceanside between April 5 and April 19 may have been exposed to hepatitis A, the Nassau County Department of Health announced late Friday.